Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer who underwent Adjuvant Osimertinib in the phase III ADAURA trial

2022 ◽  
pp. clincanres.3530.2021
Author(s):  
Margarita Majem ◽  
Jonathan W. Goldman ◽  
Thomas John ◽  
Christian Grohe ◽  
Konstantin Laktionov ◽  
...  
PLoS ONE ◽  
2015 ◽  
Vol 10 (7) ◽  
pp. e0132568 ◽  
Author(s):  
Christine Rotonda ◽  
Amélie Anota ◽  
Mariette Mercier ◽  
Bérangère Bastien ◽  
Gisèle Lacoste ◽  
...  

2015 ◽  
Vol 25 (6) ◽  
pp. 1441-1449 ◽  
Author(s):  
Szu-Chun Yang ◽  
Wu-Wei Lai ◽  
Tzuen-Ren Hsiue ◽  
Wu-Chou Su ◽  
Cheng-Kuan Lin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document